Drug General Information
Drug ID	D0S4DV
Former ID	DNC014836
Drug Name	CALYSTEGINE B2
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[551364]
Structure		Download 2D MOL 3D MOL
Formula	C7H13NO4
Canonical SMILES	C1CC2(C(C(C(C1N2)O)O)O)O
InChI	1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6+,7-/m1/s1
InChIKey	FXFBVZOJVHCEDO-IBISWUOJSA-N
PubChem Compound ID	124434
Target and Pathway
Target(s)	Alpha-galactosidase A	Target Info	Inhibitor	[551364]
KEGG Pathway	Galactose metabolism
	Glycerolipid metabolism
	Sphingolipid metabolism
	Glycosphingolipid biosynthesis - globo series
	Lysosome
PathWhiz Pathway	Sphingolipid Metabolism
	Galactose Metabolism
Reactome	Glycosphingolipid metabolism
WikiPathways	Sphingolipid metabolism
References
Ref 551364	Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity. J Nat Prod. 1995 Jun;58(6):878-86.
Ref 551364	Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity. J Nat Prod. 1995 Jun;58(6):878-86.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.